Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CIRDvalid

Financiado

Cerrado

CIRDvalid Clinical validation of a set of 11 biomarkers and a system of diagno...

CIRDvalid Clinical validation of a set of 11 biomarkers and a system of diagnostic and therapeutical devices for the resuscitation of patients suffering from long lasting cardiac arrest For decades there has been no significant improvement in resuscitation-therapy of patients suffering from cardiac arrest. Only 3% survive out-of-hospital and only 18% survive in-hospital resuscitation. The time-frame for a success... ver más

30/09/2015

RESUSCITEC

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

RESUSCITEC GMBH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2015-09-30

PHC-12-2015-1: Clinical research for the validatio...

I+D

Cerrada hace 9 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

RESUSCITEC

50.00K€ | Lider

Proyectos interesantes

CIRDinnova

Medical Technol...

Data Science

3M€ Cerrado

CardioProtectMI

Medical Technol...

Biotechnology

71K€ Cerrado

PID2019-107332RB-I00

Medical Technol...

Data Science

375K€ Cerrado

microCardio

Medical Technol...

Data Science

149K€ Cerrado

SHOCKOMICS

Medical Technol...

Data Science

7M€ Cerrado

RTI2018-094396-B-I00

Medical Technol...

Data Science

58K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 4 meses Fecha Inicio: 2015-05-25
Fecha Fin: 2015-09-30

Líder del proyecto

RESUSCITEC GMBH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto For decades there has been no significant improvement in resuscitation-therapy of patients suffering from cardiac arrest. Only 3% survive out-of-hospital and only 18% survive in-hospital resuscitation. The time-frame for a successful resuscitation is only about 3 to 5 minutes after cardiac arrest. To increase this time-frame significantly ResuSciTec has developed a new therapeutical concept to induce a paradigmatic shift in resuscitation therapy. This new concept called controlled whole body reperfusion is based on a set of 11 known biomarkers which have been validated in animal studies. ResuSciTec has produced proof of concept in preclinical animal studies for successful resuscitation after 20 minutes of cardiac arrest. About 90% of the animals (pigs) survive without or nearly without neurological damage. To perform this new therapy ResuSciTec has developed an innovative Diagnostic Medical Device for measurement of the 11 biomarkers called BioM-11. This Device will be integrated in an innovative therapeutical system called CIRD - Controlled Integrated Resuscitation Device. The proposed feasibility study (Phase 1) will provide: (1) planning of clinical studies (2) Verification and Validation planning for the devices (3) elaboration of a businessplan including milestones, market-study, roadmap for certification and reimbursement strategy. The overall innovation project (Phase 2) has four objectives: (1) Clinical validation of 11 biomarkers in humans for resuscitation-therapy in clinical studies (2) validation and CE-approval of the diagnostic device BioM-11 (3) validation and CE-approval of the CIRD 2.0-system for the resuscitation of patients (4) Clinical validation of the CIRD 2.0-system in-hospital and out-of hospital in 10 to 15 clinical centres in Europe to provide evidence for the new therapy called controlled whole body reperfusion. The overall project aims to show European leadership in this important field of emergency medicine.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores